NEW YORK--(BUSINESS WIRE)--ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that the Company is scheduled to present at the Cowen & Company 28th Annual Health Care Conference in Boston on Monday, March 17, 2008 at 3:15 p.m. EDT. A corporate overview will be provided, including additional information on the Company’s product portfolio.
